Karyopharm Therapeutics Inc. · NASDAQ:KPTI
Abate Kristin sold 4,788 Karyopharm Therapeutics Inc. shares (Form 4)
Traded Oct 16, 2026 · Filed Oct 19, 2026
On Oct 16, 2026, Abate Kristin (Chief Accounting Officer) sold 4,788 Karyopharm Therapeutics Inc. shares at US$0.34 for US$1,647, leaving 18,616 shares. Filed Oct 19, 2026 (Form 4).
- Sold
- 4,788 shares
- Price
- US$0.34
- Value
- US$1,647
- Holding after
- 18,616 shares
- Trading plan
- No
- Role
- Chief Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 16, 2026 | Common Stock | Sale | 4,788 | US$0.34 | 18,616 | Direct |
Source
Download original · View original at SEC
Related
- Karyopharm Therapeutics Inc.
- Abate Kristin
- Karyopharm Therapeutics Inc. shareholders
- Form 4 · Abate Kristin · Oct 2, 2026
- Form 4 · Abate Kristin · Sep 2, 2026
- Form 4 · Abate Kristin · May 15, 2026
- Schedule 13G/A · Anders Hove · Oct 8, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026
- Schedule 13G · Millennium Management LLC · Sep 4, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026